{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:33:51Z","timestamp":1794490431802,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Platinum-resistant high-grade serous ovarian carcinoma (HGSOC) is a major clinical challenge, with high mortality rates and no effective therapeutic options. Metabolic adaptations\u2014including enhanced lipid catabolism, oxidative phosphorylation (OXPHOS), and autophagy\u2014are major drivers of chemoresistance; however, the molecular mechanisms underpinning this metabolic reprogramming remain poorly understood. Carboxylesterase 1 (CES1), an NF-\u03baB-regulated neutral lipase, supports malignant cell survival under nutrient-depleted conditions in other cancers, but its role in HGSOC has not been explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated the role of CES1 in i) epithelial ovarian cancer (EOC) cell lines across different histological subtypes, ii) primary HGSOC cells, iii) syngeneic and platinum-resistant HGSOC mouse models. Glucose and serum limitation was used to model metabolic stress associated with platinum resistance. CES1 activity was blocked both genetically and pharmacologically using the specific CES1 inhibitor GR-148672X. Metabolic profiling, survival analysis, lipid-droplet dynamics and autophagy assays were performed. Clinical significance was evaluated by analyzing The Cancer Genome Atlas (TCGA) cohort, stratified by chemotherapy response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Metabolic stress induced a shift from glycolysis to OXPHOS and promoted platinum resistance in EOC cells. This adaptation was coincident with an upregulation of CES1, which supported lipolysis, fatty acid oxidation, and autophagy\/lipophagy. CES1 inhibition disrupted these processes leading to apoptosis\/ferroptosis in platinum-resistant EOC lines. Oleate supplementation effectively reversed CES1-mediated biological effects, confirming their dependence on CES1-driven lipid mobilization. CES1 blockade also killed primary HGSOC cells with oxidative dependency for survival, impaired tumor growth and metastatic dissemination in\n                      <jats:italic>Trp53<\/jats:italic>\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      ID8-Luc allografts and retained robust antitumor activity in platinum-resistant HGSOC xenografts. Further, in the TCGA dataset, an elevated CES1\/Carnitine Palmitoyl-transferase 1A (CPT1A) gene signature correlated with shorter overall survival (OS) and disease-specific survival (DSS) in chemoresistant, but not chemosensitive patients with HGSOC, underscoring the clinical significance of this metabolic axis in platinum resistance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CES1 is a key checkpoint governing metabolic plasticity in EOC including HGSOC, by linking lipid catabolism, OXPHOS, and autophagy to chemoresistance under conditions of metabolic pressure. Targeting CES1 selectively compromises tumor cell survival under nutrient deprivation, uncovering a metabolic vulnerability that may be exploited\u00a0to treat aggressive platinum-resistant HGSOC\u00a0that rely on OXPHOS to thrive.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-026-03766-8","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:55:02Z","timestamp":1784879702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Carboxylesterase 1 is a core metabolic vulnerability of platinum-resistant high-grade serous ovarian carcinoma"],"prefix":"10.1186","volume":"45","author":[{"given":"Irene","family":"Flati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Vecchiotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Fiorenza","family":"Di Giovanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Verzella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Dall\u2019Aglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Sarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Battistini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Zambuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Frisullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Cornice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Nunzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Di Vito Nolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry J.","family":"Whitwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Veglianti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiz Nadeem","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saverio","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Franzoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugo","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Alesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Zazzeroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"Capece","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"10","key":"3766_CR1","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.annonc.2023.07.011","volume":"34","author":"A Gonz\u00e1lez-Mart\u00edn","year":"2023","unstructured":"Gonz\u00e1lez-Mart\u00edn A, Harter P, Leary A, Lorusso D, Miller RE, Pothuri B, et al. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(10):833\u201348. https:\/\/doi.org\/10.1016\/j.annonc.2023.07.011.","journal-title":"Ann Oncol"},{"issue":"11","key":"3766_CR2","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrc4019","volume":"15","author":"DD Bowtell","year":"2015","unstructured":"Bowtell DD, B\u00f6hm S, Ahmed AA, Aspuria PJ, Bast RC, Beral V, et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015;15(11):668\u201379. https:\/\/doi.org\/10.1038\/nrc4019.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3766_CR3","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1038\/s41467-024-47271-y","volume":"15","author":"E Denisenko","year":"2024","unstructured":"Denisenko E, De Kock L, Tan A, Beasley AB, Beilin M, Jones ME, et al. Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones. Nat Commun. 2024;15(1):2860. https:\/\/doi.org\/10.1038\/s41467-024-47271-y.","journal-title":"Nat Commun"},{"issue":"12","key":"3766_CR4","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1002\/cncr.32004","volume":"125","author":"RC Bast","year":"2019","unstructured":"Bast RC, Matulonis UA, Sood AK, Ahmed AA, Amobi AE, Balkwill FR, et al. Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference. Cancer. 2019;125(12):1963\u201372. https:\/\/doi.org\/10.1002\/cncr.32004.","journal-title":"Cancer"},{"issue":"4","key":"3766_CR5","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.21037\/gs-20-325","volume":"9","author":"S Garzon","year":"2020","unstructured":"Garzon S, Lagan\u00e0 AS, Casarin J, Raffaelli R, Cromi A, Franchi M, et al. Secondary and tertiary ovarian cancer recurrence: what is the best management? Gland Surg. 2020;9(4):1118\u201329. https:\/\/doi.org\/10.21037\/gs-20-325.","journal-title":"Gland Surg"},{"issue":"1","key":"3766_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12943-025-02345-3","volume":"24","author":"H Alizadeh","year":"2025","unstructured":"Alizadeh H, Akbarabadi P, Dadfar A, Tareh MR, Soltani B. A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities. Mol Cancer. 2025;24(1):135. https:\/\/doi.org\/10.1186\/s12943-025-02345-3.","journal-title":"Mol Cancer"},{"key":"3766_CR7","doi-asserted-by":"publisher","unstructured":"Lisio MA, Fu L, Goyeneche A, Gao Z hua, Telleria C. High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints. Int J Mol Sci. 2019;20(4):952. https:\/\/doi.org\/10.3390\/ijms20040952.","DOI":"10.3390\/ijms20040952"},{"issue":"12","key":"3766_CR8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41571-023-00819-1","volume":"20","author":"AC Veneziani","year":"2023","unstructured":"Veneziani AC, Gonzalez-Ochoa E, Alqaisi H, Madariaga A, Bhat G, Rouzbahman M, et al. Heterogeneity and treatment landscape of ovarian carcinoma. Nat Rev Clin Oncol. 2023;20(12):820\u201342. https:\/\/doi.org\/10.1038\/s41571-023-00819-1.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"3766_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tcb.2022.09.009","volume":"33","author":"M Parlani","year":"2023","unstructured":"Parlani M, Jorgez C, Friedl P. Plasticity of cancer invasion and energy metabolism. Trends Cell Biol. 2023;33(5):388\u2013402. https:\/\/doi.org\/10.1016\/j.tcb.2022.09.009.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"3766_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19(2):121\u201335. https:\/\/doi.org\/10.1038\/nrm.2017.95.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3766_CR11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.18632\/oncotarget.28241","volume":"13","author":"S Chaudhry","year":"2022","unstructured":"Chaudhry S, Thomas SN, Simmons GE Jr. Targeting lipid metabolism in the treatment of ovarian cancer. Oncotarget. 2022;13(1):768\u201383. https:\/\/doi.org\/10.18632\/oncotarget.28241.","journal-title":"Oncotarget"},{"issue":"11","key":"3766_CR12","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.3390\/pharmaceutics15112610","volume":"15","author":"A Cunha","year":"2023","unstructured":"Cunha A, Silva PMA, Sarmento B, Queir\u00f3s O. Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance. Pharmaceutics. 2023;15(11):2610. https:\/\/doi.org\/10.3390\/pharmaceutics15112610.","journal-title":"Pharmaceutics"},{"issue":"12","key":"3766_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100471","volume":"2","author":"D Huang","year":"2021","unstructured":"Huang D, Chowdhury S, Wang H, Savage SR, Ivey RG, Kennedy JJ, et al. Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer. Cell Rep Med. 2021;2(12):100471. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100471.","journal-title":"Cell Rep Med"},{"issue":"11","key":"3766_CR14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137845","volume":"131","author":"D Capece","year":"2021","unstructured":"Capece D, D\u2019Andrea D, Begalli F, Goracci L, Tornatore L, Alexander JL, et al. Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinoma. J Clin Invest. 2021;131(11):e137845. https:\/\/doi.org\/10.1172\/JCI137845.","journal-title":"J Clin Invest"},{"issue":"2","key":"3766_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.163624","volume":"8","author":"G Li","year":"2023","unstructured":"Li G, Li X, Mahmud I, Ysaguirre J, Fekry B, Wang S, et al. Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy. JCI Insight. 2023;8(2):e163624. https:\/\/doi.org\/10.1172\/jci.insight.163624.","journal-title":"JCI Insight"},{"issue":"20","key":"3766_CR16","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1158\/0008-5472.CAN-16-1272","volume":"76","author":"J Walton","year":"2016","unstructured":"Walton J, Blagih J, Ennis D, Leung E, Dowson S, Farquharson M, et al. CRISPR\/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma. Cancer Res. 2016;76(20):6118\u201329. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1272.","journal-title":"Cancer Res"},{"issue":"10","key":"3766_CR17","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/ncb2324","volume":"13","author":"C Mauro","year":"2011","unstructured":"Mauro C, Leow SC, Anso E, Rocha S, Thotakura AK, Tornatore L, et al. NF-\u03baB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nat Cell Biol. 2011;13(10):1272\u20139. https:\/\/doi.org\/10.1038\/ncb2324.","journal-title":"Nat Cell Biol"},{"issue":"16","key":"3766_CR18","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1016\/j.molcel.2022.06.003","volume":"82","author":"J Zhou","year":"2022","unstructured":"Zhou J, Simon JM, Liao C, Zhang C, Hu L, Zurlo G, et al. An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma. Mol Cell. 2022;82(16):3030-3044.e8. https:\/\/doi.org\/10.1016\/j.molcel.2022.06.003.","journal-title":"Mol Cell"},{"issue":"10","key":"3766_CR19","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.1021\/cr200075y","volume":"111","author":"JZ Long","year":"2011","unstructured":"Long JZ, Cravatt BF. The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease. Chem Rev. 2011;111(10):6022\u201363. https:\/\/doi.org\/10.1021\/cr200075y.","journal-title":"Chem Rev"},{"issue":"1","key":"3766_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nrd3620","volume":"11","author":"DA Bachovchin","year":"2012","unstructured":"Bachovchin DA, Cravatt BF. The pharmacological landscape and therapeutic potential of serine hydrolases. Nat Rev Drug Discov. 2012;11(1):52\u201368. https:\/\/doi.org\/10.1038\/nrd3620.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"3766_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41419-024-06765-9","volume":"15","author":"C Licini","year":"2024","unstructured":"Licini C, Morroni G, Lucarini G, Vitto VAM, Orlando F, Missiroli S, et al. ER-mitochondria association negatively affects wound healing by regulating NLRP3 activation. Cell Death Dis. 2024;15(6):407. https:\/\/doi.org\/10.1038\/s41419-024-06765-9.","journal-title":"Cell Death Dis"},{"issue":"13","key":"3766_CR22","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1016\/j.celrep.2017.03.015","volume":"18","author":"C Francavilla","year":"2017","unstructured":"Francavilla C, Lupia M, Tsafou K, Villa A, Kowalczyk K, RakownikowJersie-Christensen R, et al. Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer. Cell Rep. 2017;18(13):3242\u201356. https:\/\/doi.org\/10.1016\/j.celrep.2017.03.015.","journal-title":"Cell Rep"},{"issue":"5","key":"3766_CR23","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1158\/0008-5472.CAN-17-1833","volume":"78","author":"D Verzella","year":"2018","unstructured":"Verzella D, Bennett J, Fischietti M, Thotakura AK, Recordati C, Pasqualini F, et al. GADD45\u03b2 Loss Ablates Innate Immunosuppression in Cancer. Cancer Res. 2018;78(5):1275\u201392. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1833.","journal-title":"Cancer Res"},{"issue":"1","key":"3766_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13046-026-03658-x","volume":"45","author":"MV Giuli","year":"2026","unstructured":"Giuli MV, Mancusi A, Natiello B, Di Cristofano S, Reali R, Pignataro MG, et al. Prolyl-isomerase Pin1 drives platinum resistance by regulating Notch3 stability and function in ovarian cancer. J Exp Clin Cancer Res. 2026;45(1):71. https:\/\/doi.org\/10.1186\/s13046-026-03658-x.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"3766_CR25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314\u20136. https:\/\/doi.org\/10.1038\/nbt.3772.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"3766_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell. 2018;173(2):400-416.e11. https:\/\/doi.org\/10.1016\/j.cell.2018.02.052.","journal-title":"Cell"},{"key":"3766_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.17.00096","volume":"2","author":"VM Villalobos","year":"2018","unstructured":"Villalobos VM, Wang YC, Sikic BI. Reannotation and Analysis of Clinical and Chemotherapy Outcomes in the Ovarian Data Set From The Cancer Genome Atlas. JCO Clin Cancer Inform. 2018;2:1\u201316. https:\/\/doi.org\/10.1200\/CCI.17.00096.","journal-title":"JCO Clin Cancer Inform"},{"issue":"16","key":"3766_CR28","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1016\/j.cell.2023.07.004","volume":"186","author":"S Chowdhury","year":"2023","unstructured":"Chowdhury S, Kennedy JJ, Ivey RG, Murillo OD, Hosseini N, Song X, et al. Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell. 2023;186(16):3476-3498.e35. https:\/\/doi.org\/10.1016\/j.cell.2023.07.004.","journal-title":"Cell"},{"issue":"11","key":"3766_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.777273","volume":"23","author":"L Cai","year":"2021","unstructured":"Cai L, Ying M, Wu H. Microenvironmental Factors Modulating Tumor Lipid Metabolism: Paving the Way to Better Antitumoral Therapy. Front Oncol. 2021;23(11):777273. https:\/\/doi.org\/10.3389\/fonc.2021.777273.","journal-title":"Front Oncol"},{"issue":"10","key":"3766_CR30","doi-asserted-by":"publisher","first-page":"1153986","DOI":"10.3389\/fnut.2023.1153986","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Ding HM, Deng LF, Chen GC, Li J, He ZY, et al. Dietary fats and serum lipids in relation to the risk of ovarian cancer: a meta-analysis of observational studies. Front Nutr. 2023;14(10):1153986. https:\/\/doi.org\/10.3389\/fnut.2023.1153986.","journal-title":"Front Nutr"},{"issue":"11","key":"3766_CR31","doi-asserted-by":"publisher","first-page":"1104514","DOI":"10.3389\/fcell.2023.1104514","volume":"13","author":"A McCabe","year":"2023","unstructured":"McCabe A, Zaheed O, McDade SS, Dean K. Investigating the suitability of in vitro cell lines as models for the major subtypes of epithelial ovarian cancer. Front Cell Dev Biol. 2023;13(11):1104514. https:\/\/doi.org\/10.3389\/fcell.2023.1104514.","journal-title":"Front Cell Dev Biol"},{"key":"3766_CR32","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.2337\/db18-1210","volume":"68","author":"L Yang","year":"2019","unstructured":"Yang L, Li X, Tang H, Gao Z, Zhang K, Sun K. A Unique Role of Carboxylesterase 3 (Ces3) in b-Adrenergic Signaling-Stimulated Thermogenesis. Diabetes. 2019;68:1178\u201396.","journal-title":"Diabetes"},{"issue":"8","key":"3766_CR33","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101209","volume":"5","author":"G Li","year":"2022","unstructured":"Li G, Li X, Yang L, Wang S, Dai Y, Fekry B, et al. Adipose tissue\u2013specific ablation of Ces1d causes metabolic dysregulation in mice. Life Sci Alliance. 2022;5(8):e202101209. https:\/\/doi.org\/10.26508\/lsa.202101209.","journal-title":"Life Sci Alliance"},{"key":"3766_CR34","doi-asserted-by":"publisher","unstructured":"S SK, N Swamya S, Devaraj V, Premalathac C, Pallavi VR, Sagar BC, et al. Metabolic Reprogramming and Lipophagy Mediates Survival of Ascites Derived Metastatic Ovarian Cancer Cells. Asian Pac J Cancer Prev. 2022;23(5):1699\u2013709. https:\/\/doi.org\/10.31557\/APJCP.2022.23.5.1699.","DOI":"10.31557\/APJCP.2022.23.5.1699"},{"key":"3766_CR35","doi-asserted-by":"publisher","unstructured":"Zhang J, Yan H, Fu Y. Effects of Autophagy\u2010Related Genes on the Prognosis and Immune Microenvironment of Ovarian Cancer. Gas P, editor. BioMed Res Int. 2022;2022(1):6609195. https:\/\/doi.org\/10.1155\/2022\/6609195.","DOI":"10.1155\/2022\/6609195"},{"issue":"3","key":"3766_CR36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.molcel.2014.12.013","volume":"57","author":"R Huang","year":"2015","unstructured":"Huang R, Xu Y, Wan W, Shou X, Qian J, You Z, et al. Deacetylation of Nuclear LC3 Drives Autophagy Initiation under Starvation. Mol Cell. 2015;57(3):456\u201366. https:\/\/doi.org\/10.1016\/j.molcel.2014.12.013.","journal-title":"Mol Cell"},{"issue":"7242","key":"3766_CR37","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"R Singh","year":"2009","unstructured":"Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature. 2009;458(7242):1131\u20135. https:\/\/doi.org\/10.1038\/nature07976.","journal-title":"Nature"},{"issue":"10","key":"3766_CR38","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1083\/jcb.201803153","volume":"218","author":"MB Schott","year":"2019","unstructured":"Schott MB, Weller SG, Schulze RJ, Krueger EW, Drizyte-Miller K, Casey CA, et al. Lipid droplet size directs lipolysis and lipophagy catabolism in hepatocytes. J Cell Biol. 2019;218(10):3320\u201335. https:\/\/doi.org\/10.1083\/jcb.201803153.","journal-title":"J Cell Biol"},{"issue":"6","key":"3766_CR39","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/biology12060864","volume":"12","author":"F Chen","year":"2023","unstructured":"Chen F, Kang R, Liu J, Tang D. The ACSL4 Network Regulates Cell Death and Autophagy in Diseases. Biology. 2023;12(6):864. https:\/\/doi.org\/10.3390\/biology12060864.","journal-title":"Biology"},{"issue":"13","key":"3766_CR40","doi-asserted-by":"publisher","first-page":"1231460","DOI":"10.3389\/fonc.2023.1231460","volume":"22","author":"J Yan","year":"2023","unstructured":"Yan J, Xu F, Zhou D, Zhang S, Zhang B, Meng Q, et al. Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer. Front Oncol. 2023;22(13):1231460. https:\/\/doi.org\/10.3389\/fonc.2023.1231460.","journal-title":"Front Oncol"},{"issue":"7","key":"3766_CR41","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/1541-7786.MCR-19-1057","volume":"18","author":"BT Sawyer","year":"2020","unstructured":"Sawyer BT, Qamar L, Yamamoto TM, McMellen A, Watson ZL, Richer JK, et al. Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression. Mol Cancer Res. 2020;18(7):1088\u201398. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-1057.","journal-title":"Mol Cancer Res"},{"issue":"9","key":"3766_CR42","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/cdd.2016.39","volume":"23","author":"DS Matassa","year":"2016","unstructured":"Matassa DS, Amoroso MR, Lu H, Avolio R, Arzeni D, Procaccini C, et al. Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer. Cell Death Differ. 2016;23(9):1542\u201354. https:\/\/doi.org\/10.1038\/cdd.2016.39.","journal-title":"Cell Death Differ"},{"issue":"11","key":"3766_CR43","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17(11):1498\u2013503. https:\/\/doi.org\/10.1038\/nm.2492.","journal-title":"Nat Med"},{"issue":"1","key":"3766_CR44","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cmet.2018.09.002","volume":"29","author":"G Gentric","year":"2019","unstructured":"Gentric G, Kieffer Y, Mieulet V, Goundiam O, Bonneau C, Nemati F, et al. PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers. Cell Metab. 2019;29(1):156-173.e10. https:\/\/doi.org\/10.1016\/j.cmet.2018.09.002.","journal-title":"Cell Metab"},{"issue":"16","key":"3766_CR45","doi-asserted-by":"publisher","first-page":"1528230","DOI":"10.3389\/fimmu.2025.1528230","volume":"3","author":"P Jalali","year":"2025","unstructured":"Jalali P, Shahmoradi A, Samii A, Mazloomnejad R, Hatamnejad MR, Saeed A, et al. The role of autophagy in cancer: from molecular mechanism to therapeutic window. Front Immunol. 2025;3(16):1528230. https:\/\/doi.org\/10.3389\/fimmu.2025.1528230.","journal-title":"Front Immunol"},{"issue":"7","key":"3766_CR46","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.devcel.2021.02.010","volume":"56","author":"DR Miller","year":"2021","unstructured":"Miller DR, Thorburn A. Autophagy and organelle homeostasis in cancer. Dev Cell. 2021;56(7):906\u201318. https:\/\/doi.org\/10.1016\/j.devcel.2021.02.010.","journal-title":"Dev Cell"},{"issue":"5","key":"3766_CR47","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1101\/gad.2016311","volume":"25","author":"JY Guo","year":"2011","unstructured":"Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011;25(5):460\u201370. https:\/\/doi.org\/10.1101\/gad.2016311.","journal-title":"Genes Dev"},{"issue":"2","key":"3766_CR48","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41419-022-04593-3","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Peng X, Yang S, Li X, Huang M, Wei S, et al. The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders. Cell Death Dis. 2022;13(2):132. https:\/\/doi.org\/10.1038\/s41419-022-04593-3.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3766_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cell.2019.12.005","volume":"180","author":"M Sch\u00fctter","year":"2020","unstructured":"Sch\u00fctter M, Giavalisco P, Brodesser S, Graef M. Local Fatty Acid Channeling into Phospholipid Synthesis Drives Phagophore Expansion during Autophagy. Cell. 2020;180(1):135-149.e14. https:\/\/doi.org\/10.1016\/j.cell.2019.12.005.","journal-title":"Cell"},{"issue":"6","key":"3766_CR50","doi-asserted-by":"publisher","first-page":"1902847","DOI":"10.1002\/advs.201902847","volume":"7","author":"B Yang","year":"2020","unstructured":"Yang B, Ding L, Chen Y, Shi J. Augmenting Tumor-Starvation Therapy by Cancer Cell Autophagy Inhibition. Adv Sci. 2020;7(6):1902847. https:\/\/doi.org\/10.1002\/advs.201902847.","journal-title":"Adv Sci"},{"key":"3766_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216659","volume":"587","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu L, Tian Y, Gu M, Wang Y, Ashrafizadeh M, et al. Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics. Cancer Lett. 2024;587:216659. https:\/\/doi.org\/10.1016\/j.canlet.2024.216659.","journal-title":"Cancer Lett"},{"issue":"22","key":"3766_CR52","doi-asserted-by":"publisher","first-page":"16503","DOI":"10.3390\/ijms242216503","volume":"24","author":"Q Ma","year":"2023","unstructured":"Ma Q, Liu Z, Wang T, Zhao P, Liu M, Wang Y, et al. Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN. Int J Mol Sci. 2023;24(22):16503. https:\/\/doi.org\/10.3390\/ijms242216503.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3766_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21(2):141\u201362. https:\/\/doi.org\/10.1038\/s41573-021-00339-6.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"3766_CR54","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41416-023-02394-9","volume":"129","author":"ND Machado","year":"2023","unstructured":"Machado ND, Heather LC, Harris AL, Higgins GS. Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities. Br J Cancer. 2023;129(6):897\u20139. https:\/\/doi.org\/10.1038\/s41416-023-02394-9.","journal-title":"Br J Cancer"},{"issue":"1","key":"3766_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","volume":"29","author":"TA Yap","year":"2023","unstructured":"Yap TA, Daver N, Mahendra M, Zhang J, Kamiya-Matsuoka C, Meric-Bernstam F, et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat Med. 2023;29(1):115\u201326. https:\/\/doi.org\/10.1038\/s41591-022-02103-8.","journal-title":"Nat Med"},{"issue":"3","key":"3766_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2010.02.005","volume":"11","author":"E Wei","year":"2010","unstructured":"Wei E, Ben Ali Y, Lyon J, Wang H, Nelson R, Dolinsky VW, et al. Loss of TGH\/Ces3 in Mice Decreases Blood Lipids, Improves Glucose Tolerance, and Increases Energy Expenditure. Cell Metab. 2010;11(3):183\u201393. https:\/\/doi.org\/10.1016\/j.cmet.2010.02.005.","journal-title":"Cell Metab"},{"issue":"6","key":"3766_CR57","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.ajhg.2008.04.015","volume":"82","author":"HJ Zhu","year":"2008","unstructured":"Zhu HJ, Patrick KS, Yuan HJ, Wang JS, Donovan JL, DeVane CL, et al. Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis. Am J Hum Genet. 2008;82(6):1241\u20138. https:\/\/doi.org\/10.1016\/j.ajhg.2008.04.015.","journal-title":"Am J Hum Genet"},{"key":"3766_CR58","doi-asserted-by":"publisher","unstructured":"Varfolomeev SD, Lushchekina SV, Nemukhin AV, Kulakova AM, Kots ED, Makhaeva GF, et al. Molecular polymorphism of human enzymes as the basis of individual sensitivity to drugs. Supercomputer-assisted modeling as a tool for analysis of structural changes and enzymatic activity of proteins. Russ Chem Bull. 2016;65(6):1592\u2013607. https:\/\/doi.org\/10.1007\/s11172-016-1487-8.","DOI":"10.1007\/s11172-016-1487-8"}],"updated-by":[{"DOI":"10.1186\/s13046-026-03859-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:00:00Z","timestamp":1793923200000}},{"DOI":"10.1186\/s13046-026-03863-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:00:00Z","timestamp":1794268800000}}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03766-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03766-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03766-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:05:41Z","timestamp":1794488741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03766-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3766"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03766-8","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated: Figures 4,5 and 6 were updated to include correct panel labels.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13046-026-03863-8","URL":"https:\/\/doi.org\/10.1186\/s13046-026-03863-8","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human samples were collected in accordance with the Declaration of Helsinki, and the study was approved by the Ethics Committee for Clinical Research of the Istituto Europeo di Oncologia (Approval number R789-IEO). All participants provided written informed consent before their inclusion in the study.All animal experiments were approved by the Institutional Ethics Committee for Animal Use (OPBA) and by the Italian Ministry of Health (authorization numbers 1038\/2023-PR) and were performed following the 3Rs\u2019 recommendations (Reduction, Refinement and Replacement).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors confirm their consent to publish this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"217"}}